IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q3 2023 Holdings

Filed 2023-11-13 | 17 holdings | $242.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$160.0M6,068,12565.9%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$18.2M1,115,3527.5%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$14.9M1,025,0006.1%
Biomea Fusion Inc (Bmea)(BMEA)COM09077A106$11.0M798,7574.5%
Compass Pathways Plc (Cmps)(CMPS)SPONSORED ADS20451W101$7.1M964,5002.9%
Monte Rosa Therapeutics Inc (Glue)(GLUE)COM61225M102$7.1M1,472,3312.9%
Reneo Pharmaceuticals Inc (Rphm)(RPHM)COM75974E103$6.7M886,0752.8%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$3.4M2,541,0091.4%
Aclaris Theraputics Inc (Acrs)(ACRS)COM00461U105$3.0M434,4551.2%
Spruce Biosciences, Inc. (Sprb)COM85209E109$2.7M1,205,5111.1%
Poseida Therapeutics Inc. (Pstx)(PSTXUSD)COM73730P108$2.5M1,043,2671.0%
Elevation Oncology Inc (Elev)COM28623U101$1.9M2,834,9100.8%
Avrobio, Inc. (Avro)COM05455M100$1.6M1,009,7790.6%
Marker Therapeutics, Inc. (Mrkr)(MRKR)COM57055L206$1.4M314,2860.6%
Aeglea Biotherapeutics Inc (Agle)(SYRE)COM NEW00773J202$828.7K67,6450.3%
Viracta Therapeutics Inc (Virx)COM92765F108$300.1K288,5710.1%
Atreca Inc. (Bcel)(BCELUSD)CL A COM04965G109$101.2K387,6530.0%